PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

227 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
161.
Schoetz, U.* et al.: Increased CD44v6 expression confers radioresistance in subsets of HNSCC. Strahlenther. Onkol. 193, S85-S85 (2017)
162.
Straube, C.* & Combs, S.E.: Kombination von Strahlentherapie mit Temozolomid bei über 65-jährigen Glioblastompatienten. Strahlenther. Onkol. 193, 510-512 (2017)
163.
Straube, C.* et al.: Re-irradiation after gross total resection of recurrent glioblastoma: Spatial pattern of recurrence and a review of the literature as a basis for target volume definition. Strahlenther. Onkol. 193, 897–909 (2017)
164.
Straube, C.* et al.: Moving Re-Irradition forward: Generation of target volume guidelines in patients with recurrent glioblastoma following gross total resection. Strahlenther. Onkol. 193, S100-S101 (2017)
165.
Tufman, A. et al.: Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancer. Strahlenther. Onkol. 193, 392-401 (2017)
166.
Vogel, M.M. ; Kessel, K.A. & Combs, S.E.: Mobile applications in oncology: App-assisted treatment and research. Strahlenther. Onkol. 193, S171-S171 (2017)
167.
Wunderlich, R. et al.: Irradiated HPV+ head and neck cancer cells induce an interferon related gene expression in various innate immune cell subtypes. Strahlenther. Onkol. 193, S84-S84 (2017)
168.
Zahnbrecher, E.* et al.: Reduced acute side effects by proton mini beam radiation therapy in the mouse ear model. Strahlenther. Onkol. 193, S171-S171 (2017)
169.
Adeberg, S.* et al.: Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison. Strahlenther. Onkol. 192, 770-779 (2016)
170.
Combs, S.E. ; Nüsslin, F.* & Wilkens, J.J.: Individualized radiotherapy by combining high-end irradiation and magnetic resonance imaging. Strahlenther. Onkol. 192, 209-215 (2016)
172.
Combs, S.E. ; Schmidt-Graf, F.* & Meyer, B.*: Bessere Prognose von Low-grade-Gliomen durch Kombination von Bestrahlung, Procarbazin, CCNU und Vincristin. Strahlenther. Onkol. 192, 672-674 (2016)
173.
Harrabi, S.B.* et al.: Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma. Strahlenther. Onkol. 192, 759-769 (2016)
174.
Münch, S.* et al.: Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT. Strahlenther. Onkol. 192, 722-729 (2016)
175.
Specht, H.M.* et al.: HFSRT of the resection cavity in patients with brain metastases. Strahlenther. Onkol. 192, 368-376 (2016)
176.
Vaupel, P.* & Multhoff, G.: Adenosine can thwart antitumor immune responses elicited by radiotherapy : Therapeutic strategies alleviating protumor ADO activities. Strahlenther. Onkol. 192, 279-287 (2016)
177.
Combs, S.E. et al.: Clinical outcome after high-precision radiotherapy for skull base meningiomas: Pooled data from three large German Centers of Radiation Oncology. Strahlenther. Onkol. 191, S38 (2015)
178.
Dittmar, J.O.* et al.: Changes of the meningioma specific chromosomal aberration after radiotherapy with photons or carbon ions. Strahlenther. Onkol. 191, S146 (2015)
179.
Dittmar, J.O.* et al.: The [Ga-68]-DOTA-D Phe 1-3Tyr3-Octreotide (DOTATOC)- based radiotherapy planning leads to improved organ preservation risk at the proton- radiotherapy of intracranial meningiomas. Strahlenther. Onkol. 191, S151-S152 (2015)
180.
Dittmar, J.O.* et al.: An automated treatment planning leads to a significant time savings during radiosurgical treatment multiple brain metastases - an evaluation of the tools, brain metastases for brainlab. Strahlenther. Onkol. 191, S154 (2015)